Biggest News Aggregation in the World
📰 Mitochondrial Augmentation Technology News

Mitochondrial Augmentation Technology News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mitochondrial Augmentation Technology. Real-time updates on events, politics, business and more.

Minovia Therapeutics appoints Maha Radhakrishnan, Chief Medical Officer at Biogen, as board member

TIRAT HACARMEL, Israel, Jan. 05, 2023, a clinical-stage company focused on developing novel Mitochondrial Augmentation Technology (MAT) to fight mitochondrial diseases, has announced a Board appointment. Maha
United States Natalie Yivgi Ohana Astellas Pharma Maha Radhakrishnan Mitochondrial Augmentation Technology Bristol Myers Squibb

Investegate |Minovia Therapeutics Announcements | Minovia Therapeutics: Minovia Therapeutics appoints Maha Radhakrishnan, Chief Medical Officer at Biogen, as board member

Investegate announcements from Minovia Therapeutics, Minovia Therapeutics appoints Maha Radhakrishnan, Chief Medical Officer at Biogen, as board member
United States Natalie Yivgi Ohana Astellas Pharma Maha Radhakrishnan Mitochondrial Augmentation Technology Worldwide Medical At Bioverativ Therapeutics Inc

Minovia Therapeutics to Present at Biotech Showcase on Tuesday, January 10, 2023Company to be in San Francisco January 8-12, 2023, during 41st Annual J.P. Morgan Health Care Conference

Minovia Therapeutics to Present at Biotech Showcase on Tuesday, January 10, 2023Company to be in San Francisco January 8-12, 2023, during 41st Annual J.P. Morgan Health Care Conference - read this article along with other careers information, tips and advice on BioSpace
United States San Francisco Tirat Carmel H Efa Shai Melcer Natalie Yivgi Ohana

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science